We are live on ! Find out more
PGP

Prescott General Partners Portfolio holdings

AUM $1.37B
1-Year Est. Return 23.81%
This Fund
S&P 500
This Quarter Est. Return
-22.05%
1 Year Est. Return
+23.81%
3 Year Est. Return
+67.15%
5 Year Est. Return
+9.62%
10 Year Est. Return
+525.75%
AUM
$2.26B
AUM Growth
-$704M
Cap. Flow
-$11.6M
Cap. Flow %
-0.51%
Top 10 Hldgs %
99.98%
Holding
11
New
1
Increased
1
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
YELP icon
Yelp
YELP
+$16.8M
2
SER icon
Serina Therapeutics
SER
+$669K

Top Sells

Rank Stock Value
1
CACC icon
Credit Acceptance
CACC
+$28.7M
2
LCTX icon
Lineage Cell Therapeutics
LCTX
+$406K

Sector Composition

Rank Sector Weight
1 Financials 46.65%
2 Industrials 24.23%
3 Consumer Discretionary 16.74%
4 Communication Services 9.18%
5 Consumer Staples 3.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CACC icon
1
Credit Acceptance
CACC
$5.93B
$808M 35.69%
2,116,840
-71,359
-3% -$28.7M
CMPR icon
2
Cimpress
CMPR
$2.38B
$482M 21.27%
4,656,492
– –
W icon
3
Wayfair
W
$11.5B
$379M 16.74%
4,207,622
– –
WRLD icon
4
World Acceptance Corp
WRLD
$837M
$208M 9.2%
2,037,495
– –
YELP icon
5
Yelp
YELP
$1.45B
$208M 9.18%
5,943,732
+440,950
+8% +$16.8M
NUS icon
6
Nu Skin
NUS
$250M
$70.1M 3.1%
1,142,959
– –
GIC icon
7
Global Industrial
GIC
$1.36B
$50.5M 2.23%
2,114,499
– –
BFH icon
8
Bread Financial
BFH
$4.37B
$39.8M 1.76%
332,509
– –
CPRT icon
9
Copart
CPRT
$26.9B
$16.7M 0.74%
1,394,080
– –
LCTX icon
10
Lineage Cell Therapeutics
LCTX
$272M
$1.69M 0.07%
1,851,851
-264,815
-13% -$406K
SER icon
11
Serina Therapeutics
SER
$30.6M
$554K 0.02%
+5,265
New +$669K

Similar funds

DC
Dendur Capital New York $1.36B AUM 38.43% 1-Year Est. Return
FC
FORA Capital Miami, Florida $1.36B AUM 56.1% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
KRS
Kentucky Retirement Systems Frankfort, Kentucky $1.37B AUM 33.36% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.37B AUM
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return
SOS
Silver Oak Securities Jackson, Tennessee $1.37B AUM 20.67% 1-Year Est. Return

Prescott General Partners's Q4 2018 Portfolio in Review

As of Q4 2018, Prescott General Partners held 11 positions worth $2.26B, down 24% from $2.97B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Prescott General Partners's Q4 2018 filing shows 1 new, 1 increased and 2 reduced positions. Its largest new stake was Serina Therapeutics: 5,265 shares worth $554K. The largest sale was Credit Acceptance, an estimated $28.7M.

By sector, the portfolio is most concentrated in Financials at 47% of assets, up from 42% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Prescott General Partners's largest Q4 2018 buy was Serina Therapeutics: 5,265 shares worth $554K.
  • Prescott General Partners added most to Yelp in Q4 2018, an estimated $16.8M increase.
  • Prescott General Partners's biggest Q4 2018 reduction was Credit Acceptance, cutting an estimated $28.7M.
  • Prescott General Partners's ten largest holdings make up 100% of its $2.26B portfolio in Q4 2018.
  • Prescott General Partners opened 1 new position and closed 0 in Q4 2018.
  • Prescott General Partners's portfolio value fell 24% quarter-over-quarter to $2.26B.

Based on Prescott General Partners's 13F filing for Q4 2018, filed 14 Feb 2019.